Ameriprise Financial Inc Dr Reddys Laboratories LTD Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ameriprise Financial Inc holds 185,576 shares of RDY stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

185,576

Previous 198,150 6.35%

Holding current value

$14.1 Million

Previous $13.8 Million 1.28%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $846,984 - $975,616	-12,574 Reduced 6.35%	185,576 $13.6 Million
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $15.2 Million - $16.5 Million	-236,304 Reduced 54.39%	198,150 $13.8 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $590,154 - $693,789	-9,534 Reduced 2.15%	434,454 $29.1 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $2.56 Million - $3.03 Million	48,032 Added 12.13%	443,988 $28 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $18,380 - $20,267	356 Added 0.09%	395,956 $22.5 Million

Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $653,441 - $733,923	12,775 Added 3.34%	395,600 $20.5 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $41,516 - $47,690	832 Added 0.22%	382,825 $20.9 Million
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $402,467 - $471,492	8,111 Added 2.17%	381,993 $20.3 Million
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $12.5 Million - $16.9 Million	-258,767 Reduced 40.9%	373,882 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $37.6 Million - $42.5 Million	632,649 New	632,649 $35.6 Million
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $375,043 - $469,131	-6,231 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $107,405 - $128,291	-1,729 Reduced 21.72%	6,231 $458,000
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $19,191 - $24,189	331 Added 4.34%	7,960 $488,000
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $22,163 - $25,236	-354 Reduced 4.43%	7,629 $543,000
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $462 - $651	-9 Reduced 0.11%	7,983 $556,000
Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $304,139 - $420,258	-7,690 Reduced 49.04%	7,992 $424,000
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $145,880 - $192,478	4,198 Added 36.56%	15,682 $632,000
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $73,576 - $83,852	2,007 Added 21.18%	11,484 $467,000
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $158,013 - $178,161	-4,538 Reduced 32.38%	9,477 $359,000
Q2 2019 Aug 14, 2019	BUY	$36.05 - $42.76 $24,405 - $28,948	677 Added 5.08%	14,015 $525,000
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $80,947 - $91,809	2,263 Added 20.43%	13,338 $541,000
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $162,957 - $196,428	5,110 Added 85.67%	11,075 $418,000
Q3 2018 Nov 14, 2018	BUY	$29.25 - $36.73 $174,476 - $219,094	5,965 New	5,965 $207,000
Q4 2017 Feb 12, 2018	SELL	$34.15 - $37.62 $358,062 - $394,445	-10,485 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$30.11 - $37.72 $315,703 - $395,494	10,485	10,485 $374,000

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Dr Reddys Laboratories LTD Transaction History